Gravallese EM, Firestein GS (2023) Rheumatoid Arthritis - Common Origins, Divergent Mechanisms. N Engl J Med 388:529–542. https://doi.org/10.1056/NEJMra2103726

Article  CAS  PubMed  Google Scholar 

Conforti A, Di Cola I, Pavlych V et al (2021) Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev 20:102735. https://doi.org/10.1016/j.autrev.2020.102735

Article  PubMed  Google Scholar 

Jäger U, Barcellini W, Broome CM et al (2020) Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev 41:100648. https://doi.org/10.1016/j.blre.2019.100648

Article  CAS  PubMed  Google Scholar 

Ichikawa N, Harigai M, Nakajima A et al (2001) Immune thrombocytopenic purpura associated with rheumatoid arthritis - a report of five cases and review of the literature. Mod Rheumatol 11:246–250. https://doi.org/10.3109/s101650170013

Article  CAS  PubMed  Google Scholar 

Berentsen Sigbjørn B Wilma (2021) Autoimmune Hemolytic Anemias. N Engl J Med 385:1407–1419. https://doi.org/10.1056/NEJMra2033982

Article  PubMed  Google Scholar 

Michel M, Crickx E, Fattizzo B, Barcellini W (2024) Autoimmune haemolytic anaemias. Nat Rev Dis Primers 10:82. https://doi.org/10.1038/s41572-024-00566-2

Article  PubMed  Google Scholar 

Cooper N, Ghanima W (2019) Immune thrombocytopenia. N Engl J Med 381:945–955. https://doi.org/10.1056/NEJMcp1810479

Article  PubMed  Google Scholar 

Berentsen S, Ulvestad E, Gjertsen BT et al (2004) Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood 103:2925–2928. https://doi.org/10.1182/blood-2003-10-3597

Article  CAS  PubMed  Google Scholar 

Neunert C, Terrell DR, Arnold DM et al (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 3:3829–3866. https://doi.org/10.1182/bloodadvances.2019000966

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tavakolpour S, Alesaeidi S, Darvishi M et al (2019) A comprehensive review of rituximab therapy in rheumatoid arthritis patients. Clin Rheumatol 38:2977–2994. https://doi.org/10.1007/s10067-019-04699-8

Article  PubMed  Google Scholar 

Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417. https://doi.org/10.1007/s00296-011-1999-3

Article  PubMed  Google Scholar 

Malesci D, La Montagna G (2008) Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab. Rheumatology 47:734–735. https://doi.org/10.1093/rheumatology/ken076

Article  CAS  PubMed  Google Scholar 

Lehmann P, Hartung W, Ehrenstein B et al (2010) [Rheumatoid arthritis and autoimmune hemolysis: B-cell depletion for remission induction in a patient with rheumatoid arthritis and cold agglutinin disease]. Z Rheumatol 69:557–560. https://doi.org/10.1007/s00393-010-0607-3

Article  CAS  PubMed  Google Scholar 

Mitsuishi A, Miura Y, Saeki K et al (2023) Total arch replacement for an aortic arch aneurysm with cold agglutinin disease after rituximab and plasmapheresis. J Cardiothorac Surg 18:281. https://doi.org/10.1186/s13019-023-02388-x

Article  PubMed  PubMed Central  Google Scholar 

Zhang N, Ji C, Bao X, Yuan C (2022) Early treatment of rituximab combined with eltrombopag for secondary thrombocytopenic purpura in rheumatoid arthritis: A case report: A case report. Med (Baltim) 101:e28417. https://doi.org/10.1097/MD.0000000000028417

Article  Google Scholar 

Ruiz-Arguelles GJ, Ruiz-Delgado GJ, Velázquez-Sánchez-de-Cima S, Zamora-Ortiz G (2013) Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab. Hematology 18:175–177. https://doi.org/10.1179/1607845412Y.0000000060

Article  CAS  PubMed  Google Scholar 

Muñoz AM, Orozco Niño JA, Seehaus CM et al (2021) Evans syndrome and rheumatoid arthritis as autoimmune manifestations of large granular T-cell leukemia. Med (B Aires) 81:1060–1064

Google Scholar 

Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://doi.org/10.1002/art.27584

Article  PubMed  Google Scholar 

Röth A, Barcellini W, D’Sa S et al (2021) Sutimlimab in cold agglutinin disease. N Engl J Med 384:1323–1334. https://doi.org/10.1056/NEJMoa2027760

Article  PubMed  Google Scholar 

Röth A, Berentsen S, Barcellini W et al (2022) Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial. Blood 140:980–991. https://doi.org/10.1182/blood.2021014955

Article  CAS  PubMed  PubMed Central  Google Scholar 

Röth A, Berentsen S, Barcellini W et al (2024) Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B. EClinicalMedicine 74:102733. https://doi.org/10.1016/j.eclinm.2024.102733

Article  PubMed  PubMed Central  Google Scholar 

Berentsen S (2020) New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. Front Immunol 11:590. https://doi.org/10.3389/fimmu.2020.00590

Article  CAS  PubMed  PubMed Central  Google Scholar 

Honne K, Nagashima T, Iwamoto M et al (2015) Glucocorticoid-Responsive Cold Agglutinin Disease in a Patient with Rheumatoid Arthritis. Case Rep Rheumatol 2015:823563. https://doi.org/10.1155/2015/823563

Article  PubMed  PubMed Central  Google Scholar 

Kashiwagi H, Kuwana M, Hato T et al (2020) Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision. Int J Hematol 111:329–351. https://doi.org/10.1007/s12185-019-02790-z

Article  PubMed  PubMed Central  Google Scholar 

Ustun C, Kallab A, Loebl D et al (2002) Rheumatoid arthritis and immune thrombocytopenia: a report of two cases. Clin Rheumatol 21:543–544. https://doi.org/10.1007/s100670200136

Article  CAS  PubMed  Google Scholar 

Horino T, Sasaoka A, Takao T et al (2005) Immune thrombocytopenic purpura associated with rheumatoid arthritis: case report. Clin Rheumatol 24:641–644. https://doi.org/10.1007/s10067-005-1113-x

Article  PubMed  Google Scholar 

Scherer HU, van der Woude D, Toes REM (2022) From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis. Nat Rev Rheumatol 18:371–383. https://doi.org/10.1038/s41584-022-00786-4

Article  CAS  PubMed  Google Scholar 

Isaacs JD, Cohen SB, Emery P et al (2013) Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. Ann Rheum Dis 72:329–336. https://doi.org/10.1136/annrheumdis-2011-201117

Article  CAS  PubMed  Google Scholar 

Evans RS, Takahashi K, Duane RT et al (1951) Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Arch Intern Med 87:48–65. https://doi.org/10.1001/archinte.1951.03810010058005

Article  CAS  PubMed  Google Scholar 

Fattizzo B, Michel M, Giannotta JA et al (2021) Evans syndrome in adults: an observational multicenter study. Blood Adv 5:5468–5478. https://doi.org/10.1182/bloodadvances.2021005610